Cite

HARVARD Citation

    Li, Y. et al. (2022). Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis. Expert review of respiratory medicine. 16 (9), pp. 1023-1033. [Online]. 
  
Back to record